compare tirzepatide vs semaglutide for weight loss Retatrutide vs Tirzepatide vs Semaglutide: Weight Loss,

The enhanced glucose control from Retatrutide typically reduces insulin requirements

A phase 2 study evaluating the effects of 24 weeks of IMM-124e in patients with biopsy-proven MASH showed a reduction in AST and ALT but no change in hepatic fat content (NCT02316717)

RETAILER RESPONSES Retailers have said consumers are shopping more often, with smaller basket sizes, and their shift toward fresh, lean protein and less processed foods has been ongoing for several years, which makes it difficult to distinguish the exact GLP-1 impact

Taken together, the current clinical evidence suggests that tirzepatide is safe for long-term use in appropriate candidates, particularly under medical supervision with routine monitoring

(Geref International Study Group)

Vrijens B et al